United States v. Sardar Ashrafkhan

964 F.3d 574
Court of Appeals for the Sixth Circuit·Decided July 10, 2020·No. 17-1918·Published·Cited by 8 cases

Opinion

RECOMMENDED FOR PUBLICATION Pursuant to Sixth Circuit I.O.P. 32.1(b) File Name: 20a0207p.06

UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT

UNITED STATES OF AMERICA, ┐ Plaintiff-Appellee, │ │ > No. 17-1918 v. │ │ │ SARDAR ASHRAFKHAN, │ Defendant-Appellant. │ ┘

Appeal from the United States District Court for the Eastern District of Michigan at Detroit. No. 2:11-cr-20551-12—Robert H. Cleland, District Judge.

Argued: April 29, 2020

Decided and Filed: July 10, 2020

Before: BOGGS, GRIFFIN, and READLER, Circuit Judges _________________

COUNSEL

ARGUED: Kent Wicker, DRESSMAN BENZINGER LA VELLE PSC, Louisville, Kentucky, for Appellant. Wayne F. Pratt, UNITED STATES ATTORNEY’S OFFICE, Detroit, Michigan, for Appellee. ON BRIEF: Kent Wicker, DRESSMAN BENZINGER LA VELLE PSC, Louisville, Kentucky, for Appellant. Wayne F. Pratt, UNITED STATES ATTORNEY’S OFFICE, Detroit, Michigan, for Appellee. _________________

OPINION _________________

BOGGS, Circuit Judge. Sardar Ashrafkhan came to the United States in 1991 after receiving a scholarship to study at Michigan State University. He earned a Ph.D. in 1996 with a research focus on pathology and the genetics of cancer. He settled in Ypsilanti, Michigan and No. 17-1918 United States v. Ashrafkhan Page 2

soon became an active member of the community. However, according to prosecutors, Ashrafkhan’s life did not continue so wholesomely. In 2006, he founded Compassionate Doctors (“Compassionate”), a medical practice outside of Detroit. But it appears that Compassionate was nothing more than a sham, and indeed was a “pill mill,” where unscrupulous doctors would write fraudulent prescriptions for fake patients. Compassionate would then bill Medicare for the fake patient visits, and it collected millions of dollars in Medicare payments over the course of several years. Worse yet, the fraudulent prescriptions would be filled by individuals recruited by Compassionate at pharmacies that paid Compassionate kickbacks. Those drugs would then be sold on the street, resulting in hundreds of thousands of opioid-based drugs being distributed onto the illegal drug market.

Ashrafkhan was tried and convicted of one count of conspiracy to distribute controlled substances, one count of conspiracy to commit healthcare fraud, and two counts of money laundering. He was sentenced to twenty-three years of imprisonment. Ashrafkhan now appeals, raising a number of arguments against his prosecution, ranging from his indictment to his sentencing. We affirm Ashrafkhan’s conviction and sentence, writing for publication only with regard to our discussion of the jury instruction on reasonable doubt. All other issues raised by Ashrafkhan are addressed and decided in an unpublished appendix to this opinion.

I. BACKGROUND

A. Factual Background

Sardar Ashrafkhan was the owner of Compassionate Doctors (“Compassionate”), a medical clinic he established in 2006. Although from the outside, Compassionate appeared to be a real clinic that provided legitimate services, the government alleged that it was nothing more than a “pill mill”—a sham clinic where unethical doctors would prescribe large quantities of opioids to individuals who did not need them. The opioids were later sold on the street and Compassionate would bill Medicare for the fake “patient visits” that had supposedly occurred.

The scheme was simple. Compassionate would pay associates whom it called “marketers”—generally small-time criminals or drug dealers—to recruit fake patients to the clinic. These patients were not ill, nor did they visit Compassionate for any real treatment. No. 17-1918 United States v. Ashrafkhan Page 3

Instead, Compassionate’s doctors would write fraudulent prescriptions for the “patient,” often without conducting any medical examination or even seeing the patient at all. Compassionate would then bill the patient’s health insurance (Medicare) for the “visits,” while the “marketers”—in addition to the money they received from Compassionate for recruiting fake patients—would earn money by filling the fake prescriptions and selling the drugs on the street. From January 1, 2007 to January 10, 2013, Compassionate filed 65,649 Medicare Part B claims for patient visits and related procedural care, claiming over $10 million in reimbursement, of which they were ultimately paid over $6.5 million. During the same period, the government alleged that Compassionate’s prescriptions resulted in approximately 500,000 doses of controlled substances being distributed onto the illegal market. As the owner and operator of Compassionate, Ashrafkhan benefited handsomely from the scheme. Between 2008 and 2010, alone, Ashrafkhan deposited more than $2 million from Compassionate’s business account into his own personal account. When he was arrested in 2013, the government also seized over $1 million in assets.

On January 10, 2013, Ashrafkhan was charged with one count of conspiracy to distribute controlled substances, 21 U.S.C. §§ 841(a)(1), 846; one count of healthcare-fraud conspiracy, 18 U.S.C. §§ 1347, 1349; and two counts of money laundering, 18 U.S.C. § 1957. Ashrafkhan was convicted at trial of all charges. He was sentenced to an aggregate term of twenty-three years of imprisonment (276 months in total); 240 months for the drug-distribution conspiracy count, 120 months for the healthcare-fraud-conspiracy count—with 36 months to run consecutively and the remaining 84 months to run concurrently—and 120 months for the two money-laundering counts, to run concurrently.

Ashrafkhan timely appealed, making a variety of arguments. In particular, he claims that: his indictment had been constructively amended, several of his jury instructions were improper, there was prosecutorial misconduct before and during his trial, there was insufficient evidence to convict him, and the district court made several errors in its assessment of the Sentencing Guidelines. In this published opinion, we address only Ashrafkhan’s objection to his reasonable- doubt instruction. All other issues are addressed and decided in an unpublished appendix to this opinion. No. 17-1918 United States v. Ashrafkhan Page 4

II. DISCUSSION

Ashrafkhan’s primary challenge on appeal pertains to the language of the reasonable- doubt instruction that the district court gave at trial. Because Ashrafkhan objected to the instruction in the proceedings below, we review for an abuse of discretion. See United States v. Eaton, 784 F.3d 298, 306 (6th Cir. 2015). We will reverse a conviction based on improper jury instructions on abuse-of-discretion review “only if the instructions, viewed as a whole, were confusing, misleading, or prejudicial,” United States v. Morrison, 594 F.3d 543, 546 (6th Cir. 2010) (citation omitted), and a reversal of a conviction is generally unwarranted unless the instructions have clearly misstated the law, see United States v. Lawrence, 735 F.3d 385, 428 (6th Cir. 2013).

The Sixth Circuit provides the following model instruction on reasonable doubt:

Proof beyond a reasonable doubt means proof which is so convincing that you would not hesitate to rely and act on it in making the most important decisions in your own lives.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Sardar Ashrafkhan, 964 F.3d 574 (6th Cir. 2020).

964 F.3d 574 (United States v. Sardar Ashrafkhan) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Sardar Ashrafkhan
129 F.4th 980 (Sixth Circuit, 2025)
United States v. Alex Smith
Fourth Circuit, 2023
United States v. Thomas Alt
Seventh Circuit, 2023
State of Iowa v. Ethan L. Davis
Supreme Court of Iowa, 2022